In addition to the direct approach of targeting Drp1, various studies have indirectly targeted Drp1 by pharmacologically inhibiting upstream signalling pathways to demonstrate the role of Drp1-mediated mitochondrial fission in doxorubicin-induced cardiomyopathy. This evidence concerns the gene DNM1L and cardiomyopathy.